small molecule

LEVOTHYROXINE SODIUM

LEVOTHYROXINE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameLEVOTHYROXINE SODIUM
Active ingredientLEVOTHYROXINE SODIUM
Strength0.175MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2019
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.